跳至主要内容
临床试验/NCT00189800
NCT00189800已完成3 期

A Study of Solifenacin Succinate Compared to Tolterodine in Patients With Overactive Bladder

Astellas Pharma Inc10 个研究点 分布在 1 个国家开始时间: 2005年9月19日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
试验地点
10

研究概览

简要总结

The purpose of this study is to ascertain the clinical results of solifenacin succinate of PIII study conducted in the original country using Korean patients with an overactive bladder.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Symptoms of overactive bladder
  • Must be able to complete the micturition diary

排除标准

  • Pregnant or lactating
  • Clinically significant outflow obstruction
  • Significant post void residual urine
  • Significant stress incontinence
  • Urinary tract infection
  • Chronic inflammation
  • Bladder stones
  • Previous pelvic radiation therapy
  • Previous or current malignant disease of the pelvic organs
  • Uncontrolled narrow angle glaucoma
  • Urinary or gastric retention
  • Electrostimulation therapy
  • Bladder training
  • Diabetic neuropathy

研究者

申办方类型
Industry

研究点 (10)

Loading locations...

相似试验

A Study of Solifenacin Succinate Compared to... | 临床试验